Compare NPCE & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | SWBI |
|---|---|---|
| Founded | 1997 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 491.2M |
| IPO Year | 2021 | 2000 |
| Metric | NPCE | SWBI |
|---|---|---|
| Price | $14.60 | $14.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $18.33 | $14.00 |
| AVG Volume (30 Days) | 200.5K | ★ 604.2K |
| Earning Date | 05-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $99,986,000.00 | ★ $474,661,000.00 |
| Revenue This Year | $0.90 | $7.61 |
| Revenue Next Year | $24.46 | $3.72 |
| P/E Ratio | ★ N/A | $297.20 |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $7.73 |
| 52 Week High | $18.97 | $15.40 |
| Indicator | NPCE | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 67.96 |
| Support Level | $14.02 | $13.65 |
| Resistance Level | $14.72 | $15.40 |
| Average True Range (ATR) | 0.67 | 0.45 |
| MACD | 0.18 | -0.05 |
| Stochastic Oscillator | 84.06 | 68.00 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.